SIREN : 487778359
MALEVA SANTE is a French company founded 20 years ago, specialized in the sector Organisation de foires, salons professionnels et congrès. Based in LYON (69006), this company of category PME shows in 2025 a revenue of 1.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1 047 935 € | 944 707 € | 854 164 € | 771 926 € | 807 846 € | 787 140 € | 640 074 € | 827 301 € |
| Net income | 160 448 € | 121 527 € | 39 471 € | 43 084 € | 77 116 € | 137 595 € | 71 795 € | 216 793 € |
| EBITDA | 208 502 € | 161 138 € | 56 499 € | 56 453 € | 100 837 € | 184 583 € | 96 402 € | 314 730 € |
| Net margin | 15.3% | 12.9% | 4.6% | 5.6% | 9.5% | 17.5% | 11.2% | 26.2% |
In 2025, MALEVA SANTE achieves revenue of 1.0 M€. Revenue is growing positively over 8 years (CAGR: +3.0%). Vs 2024, growth of +11% (945 k€ -> 1.0 M€). After deducting consumption (0 €), gross margin stands at 1.0 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 209 k€, representing 19.9% of revenue. Positive scissor effect: EBITDA margin improves by +2.8 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 160 k€, i.e. 15.3% of revenue. This profit can be retained or distributed to shareholders.
1 047 935 €
1 047 935 €
208 502 €
208 447 €
160 448 €
19.9%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 15.3% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
0.0%
56.636%
15.279%
0.0
15.7%
In 2025, the debt ratio of MALEVA SANTE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2025, the financial autonomy of MALEVA SANTE (56.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2025, the repayment capacity of MALEVA SANTE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 230.44. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.3x. Danger: operating income does not cover interest charges, unsustainable situation.
230.441
0.328
In 2025, the liquidity ratio of MALEVA SANTE (230.44) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2025, the interest coverage of MALEVA SANTE (0.3x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 7 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 4 days. The company must finance 3 days of gap between collections and payments. WCR is negative (-21 days): operations structurally generate cash. Notable WCR improvement over the period (-166%), freeing up cash.
-61 482 €
7 j
4 j
0 j
-21 j
Based on 63 transactions of similar company sales
(all years),
the value of MALEVA SANTE is estimated at
433 572 €
(range 194 887€ - 1 237 598€).
With an EBITDA of 208 502€, the sector multiple of 1.6x is applied.
The price/revenue ratio is 0.68x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 63 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MALEVA SANTE with other companies in the same sector:
Voir toutes les statistiques du secteur Organisation de foires, salons professionnels et congrès
The revenue of MALEVA SANTE in 2025 is 1.0 M€.
Yes, MALEVA SANTE generated a net profit of 160 k€ in 2025.
The headquarters of MALEVA SANTE is located in LYON (69006), in the department Rhone.
The tax return of MALEVA SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MALEVA SANTE operates in the sector Organisation de foires, salons professionnels et congrès (NAF code 82.30Z). See the 'Sector positioning' section above to compare the company with its competitors.